当前位置： SCI文献检索 > JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY期刊下所有文献 > Urinary catecholamine excretion and behavioral differences in ADHD and normal boys.

Urinary catecholamine excretion and behavioral differences in ADHD and normal boys.

Abstract：

:Urinary catecholamine excretion was assessed in 15 boys with attention-deficit/hyperactivity disorder (ADHD) and 16 normal controls during a defined physical and mental task. Dihydroxyphenylalanine, dopamine, norepinephrine (NE), epinephrine (EPI), 3,4-dihydroxyphenylacetic acid, and 3,4-dihydroxyphenylglycol (DOPEG) concentrations were assayed by high-pressure liquid chromatography with electrochemical detection. The urinary concentration of DOPEG, an NE metabolite that has not been previously measured in ADHD, was significantly lower in the ADHD subjects than in the normal controls. There was also a trend for lower urinary EPI levels in the hyperactive boys. Stepwise multiple regression analyses demonstrated that DOPEG and EPI each contributed significantly to the variance in the behavioral symptoms within the full sample. The results are consistent with previous reports of abnormal metabolism of norepinephrine and epinephrine in ADHD. These neurochemical findings may be due to differences between ADHD and normal boys in neuronal (central or peripheral) or nonneuronal (e.g., adrenal, renal) activity. The results are also consistent with prior findings in normal children of an inverse relationship between EPI excretion and inattentive, restless behaviors. Together, these findings suggest caution in ascribing metabolite changes to ADHD or to ADHD-like behaviors that may be seen in normal children.

journal_name

J Child Adolesc Psychopharmacol

journal_title

Journal of child and adolescent psychopharmacology

authors

Hanna GL,Ornitz EM,Hariharan M

doi

10.1089/cap.1996.6.63

subject

Has Abstract

pub_date

1996-04-01 00:00:00

pages

63-73

issue

1

eissn

1044-5463

issn

1557-8992

journal_volume

6

pub_type

杂志文章

相关文献

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY文献大全
  • Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

    abstract：:Risperidone has been shown to improve serious behavioral problems in children with autism. Here we asked whether risperidone-associated improvement was related to changes in concentrations of inflammatory molecules in the serum of these subjects. Seven molecules were identified as worthy of further assessment by perfo...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2010.0134

    authors： Tobiasova Z,van der Lingen KH,Scahill L,Leckman JF,Zhang Y,Chae W,McCracken JT,McDougle CJ,Vitiello B,Tierney E,Aman MG,Arnold LE,Katsovich L,Hoekstra PJ,Volkmar F,Bothwell AL,Kawikova I

    更新日期：2011-12-01 00:00:00

  • Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.

    abstract：OBJECTIVE:To examine the basal thyroid function in pediatric Obsessive Compulsive Disorder (OCD) versus controls, and to explore the relation between baseline thyroid measures and response to clomipramine treatment, and the effects of treatment on thyroid hormones. METHODS:Sixteen children and adolescents with DSM-III...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1089/cap.2005.15.581

    authors： McCracken JT,Hanna GL

    更新日期：2005-08-01 00:00:00

  • A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report.

    abstract：:Bipolar disorder (BP) in youth is an impairing psychiatric disorder associated with high rates of relapse and recurrence. High rates of psychiatric and medical co-morbidities account for additional illness burden in pediatric BP. The elevated risk of overweight and obesity in this population is of particular concern. ...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2010.0104

    authors： Goldstein TR,Goldstein BI,Mantz MB,Bailey B,Douaihy A

    更新日期：2011-06-01 00:00:00

  • Duloxetine treatment of pediatric chronic pain and co-morbid major depressive disorder.

    abstract：:In the United States, the novel compound duloxetine has been approved for the treatment of major depressive disorder (MDD) and diabetic peripheral neuropathic pain in the adult population. There are currently no published data on the use of duloxetine in children and adolescents. This report describes the successful t...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2006.0042

    authors： Meighen KG

    更新日期：2007-02-01 00:00:00

  • Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder.

    abstract：OBJECTIVE:The goal of this study was to investigate the effect of methylphenidate (MPH) on response interference, as measured by the Stoop Color and Word Test, in children with attention deficit hyperactivity disorder (ADHD). Response interference is a core component of response inhibition that has been shown to be imp...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1089/104454602762599844

    authors： Bedard AC,Ickowicz A,Tannock R

    更新日期：2002-01-01 00:00:00

  • Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate.

    abstract：:A 10-year-old boy with a history of heart transplantation had a potentially life-threatening decrease in his cyclosporine (CSA) blood levels during administration of bupropion. Subsequently he had an increase in CSA levels while receiving methylphenidate. These occurrences represent potential drug-drug interactions in...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/104454601750284117

    authors： Lewis BR,Aoun SL,Bernstein GA,Crow SJ

    更新日期：2001-07-01 00:00:00

  • Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.

    abstract：BACKGROUND:The rate-corrected QT interval (QTc) prolongation is a risk factor for sudden cardiac death and may be induced by antipsychotic drugs. OBJECTIVE:To determine the clinical characteristics associated with QTc prolongation (440 msec or greater) in children and adolescents hospitalized for treatment of psychiat...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1089/cap.2011.0024

    authors： Correll CU,Harris J,Figen V,Kane JM,Manu P

    更新日期：2011-08-01 00:00:00

  • Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.

    abstract：OBJECTIVE:The purpose of this study was to investigate clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. METHOD:Thirty-six medication-naïve children ages 9-14 years diagnosed with attention-deficit/hyperactivity disorder (ADHD) were enrolled for 6 weeks in a crossover trial,...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1089/cap.2012.0085

    authors： Ramtvedt BE,Røinås E,Aabech HS,Sundet KS

    更新日期：2013-11-01 00:00:00

  • Employing parent, teacher, and youth self-report checklists in identifying pediatric bipolar spectrum disorders: an examination of diagnostic accuracy and clinical utility.

    abstract：:The diagnosis of bipolar spectrum disorders (BPSD) is difficult to evaluate in child and adolescent populations. The current study examines whether commonly used behavior checklists- the Child Behavior Checklist, Teacher Report Form, and the Youth Self-Report form-are clinically useful in making a differential diagnos...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1089/104454603322724869

    authors： Kahana SY,Youngstrom EA,Findling RL,Calabrese JR

    更新日期：2003-01-01 00:00:00

  • Palpebral twitching in a depressed adolescent on citalopram.

    abstract：:Current estimates suggest that between 0.4% and 8.3% of children and adolescents are affected by major depression. We report a favorable response to treatment with citalopram by a 15-year-old boy with major depression who exhibited palpebral twitching during his first 2 weeks of treatment. This may have been a side ef...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/10445460152595621

    authors： Rojas VM,Silva R

    更新日期：2001-10-01 00:00:00

  • Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.

    abstract：BACKGROUND:Despite the increased recognition of attention deficit hyperactivity disorder (ADHD) in adolescents, few controlled studies have assessed treatments for this age group. Adolescent issues, such as embarrassment at receiving medication at school and experimentation with abusable substances, have accelerated ef...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1089/10445460050167313

    authors： Bostic JQ,Biederman J,Spencer TJ,Wilens TE,Prince JB,Monuteaux MC,Sienna M,Polisner DA,Hatch M

    更新日期：2000-10-01 00:00:00

  • Obsessive-compulsive disorder secondary to brain dysgerminoma in an adolescent boy: a positron emission tomography case report.

    abstract：:The neuroanatomical model involved in the pathophysiology of obsessive-compulsive disorder (OCD) postulates a hyperactivation of orbitofrontal, limbic, and basal ganglia circuits. We report a case of OCD secondary to brain dysgerminoma affecting this circuit in an adolescent who responded to citalopram. The patient is...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/104454602760386950

    authors： Gamazo-Garrán P,Soutullo CA,Ortuño F

    更新日期：2002-10-01 00:00:00

  • Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study.

    abstract：OBJECTIVE:A recent 12-week controlled comparison demonstrated the superiority of clozapine to "high-dose" olanzapine in adolescents with treatment-refractory schizophrenia. In the present study, the authors conducted a 12-week, open-label, follow-up study to examine changes in lipid and glucose metabolism in youths mai...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1089/cap.2007.0089

    authors： Kumra S,Kranzler H,Gerbino-Rosen G,Kester HM,DeThomas C,Cullen K,Regan J,Kane JM

    更新日期：2008-08-01 00:00:00

  • Comparison of Depression and Burnout Levels of Mothers of Children with Attention-Deficit Hyperactivity Disorder Before and After Treatment.

    abstract：OBJECTIVE:This study aimed to compare the depression and burnout levels of mothers of children having attention-deficit/hyperactivity disorder (ADHD) between the child's pre- and posttreatment periods. METHOD:The study sample consisted of 40 children aged between 4 and 10 years and their mothers. Initially, 40 cases p...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2017.0050

    authors： Gokcen C,Coskun S,Kutuk MO

    更新日期：2018-06-01 00:00:00

  • Lack of effect of risperidone on core autistic symptoms: data from a longitudinal study.

    abstract：OBJECTIVE:The purpose of this study was to investigate the course of autistic symptoms, using a quantitative measure of core autistic traits, among risperidone-treated children who participated in a 10 year life course longitudinal study. METHODS:Parents completed surveys of intervention history, as well as serial sym...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2014.0055

    authors： Marrus N,Underwood-Riordan H,Randall F,Zhang Y,Constantino JN

    更新日期：2014-11-01 00:00:00

  • Decreasing Trend in the Use and Long-Term Use of Benzodiazepines Among Young Adults.

    abstract：OBJECTIVE:Patterns of benzodiazepine (BZD) use and long-term use among young adults are not well known. Our aim was to study trends in BZD use and long-term use among 18-25-year-old young adults by gender and active substance in a nationwide retrospective longitudinal register-based setting. METHODS:All Finns aged 18-...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2017.0140

    authors： Tähkäpää SM,Saastamoinen L,Airaksinen M,Tuulio-Henriksson A,Aalto-Setälä T,Kurko T

    更新日期：2018-05-01 00:00:00

  • Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.

    abstract：OBJECTIVE:Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8-10 hours, and thereafter, provide a controlled, extended drug re...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1089/cap.2017.0084

    authors： Pliszka SR,Wilens TE,Bostrom S,Arnold VK,Marraffino A,Cutler AJ,López FA,DeSousa NJ,Sallee FR,Incledon B,Newcorn JH

    更新日期：2017-08-01 00:00:00

  • Treatment receipt and outcomes from a clinic employing the attention-deficit/hyperactivity disorder treatment guideline of the children's medication algorithm project.

    abstract：OBJECTIVE:Little is known about the pattern of service receipt and outcomes from clinics implementing best practice guidelines in child mental health. This study aimed to determine these variables for a clinic that implemented an attention-deficit/hyperactivity disorder (ADHD) treatment guideline proposed by the Childr...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2014.0014

    authors： Wagner DJ,Vallerand IA,McLennan JD

    更新日期：2014-11-01 00:00:00

  • Impulsive aggression, delay discounting, and adolescent suicide attempts: effects of current psychotropic medication use and family history of suicidal behavior.

    abstract：OBJECTIVE:Impulsive-aggressive behaviors have been consistently implicated in the phenomenology, neurobiology, and familial aggregation of suicidal behavior. The purpose of this study was to extend previous work by examining laboratory behavioral measures of delayed reward impulsivity and impulsive aggression in adoles...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2014.0042

    authors： Bridge JA,Reynolds B,McBee-Strayer SM,Sheftall AH,Ackerman J,Stevens J,Mendoza K,Campo JV,Brent DA

    更新日期：2015-03-01 00:00:00

  • Screening for adolescent depression: comparison of the Kutcher Adolescent Depression Scale with the Beck depression inventory.

    abstract：:Self-report instruments commonly used to assess depression in adolescents have limited or unknown reliability and validity in this age group. We describe a new self-report scale, the Kutcher Adolescent Depression Scale (KADS), designed specifically to diagnose and assess the severity of adolescent depression. This rep...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/104454602760219153

    authors： LeBlanc JC,Almudevar A,Brooks SJ,Kutcher S

    更新日期：2002-07-01 00:00:00

  • Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity.

    abstract：OBJECTIVE:Guanfacine has been shown to reduce hyperactive behaviors in children with attention-deficit/hyperactivity disorder (ADHD) and possibly in children with pervasive developmental disorder (PDD) and hyperactivity. The aim of this exploratory study was to examine whether gene variants encoding the multidrug resis...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1089/cap.2009.0059

    authors： McCracken JT,Aman MG,McDougle CJ,Tierney E,Shiraga S,Whelan F,Arnold LE,Posey D,Ritz L,Vitiello B,Scahill L

    更新日期：2010-02-01 00:00:00

  • Relative cardiovascular safety of psychostimulants used to treat attention-deficit hyperactivity disorder.

    abstract：:ABSTRACT The pertinent literature was reviewed on cardiovascular changes induced by psychostimulant medication treatment of hyperactive children. An assessment of 15 controlled studies using test doses of methylphenidate revealed a significant elevation of the resting heart rate in previously unmedicated children (mea...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.1992.2.279

    authors： Safer DJ

    更新日期：1992-01-01 00:00:00

  • Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.

    abstract：BACKGROUND:Despite its high chronicity, few studies have evaluated the effectiveness of long-term treatment for pediatric obsessive-compulsive disorder (OCD). The goal of the current analysis is to evaluate remission among children and adolescents with OCD treated with sertraline for 12 months. METHODS:Children (6-12 ...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1089/104454603322126340

    authors： Wagner KD,Cook EH,Chung H,Messig M

    更新日期：2003-01-01 00:00:00

  • Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.

    abstract：OBJECTIVE:The purpose of this study was to evaluate the efficacy and safety of acute quetiapine monotherapy in adolescents with schizophrenia. METHODS:Patients ages 13-17 years with an American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR) diagnosis ...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1089/cap.2011.0092

    authors： Findling RL,McKenna K,Earley WR,Stankowski J,Pathak S

    更新日期：2012-10-01 00:00:00

  • Anxiety and Gender Influence Reward-Related Processes in Children and Adolescents.

    abstract：OBJECTIVE:This study examined the effects of pediatric anxiety and its interaction with gender on reward processes. Based on the purported greater sensitivity to risk in females than males and the propensity for risk aversion in anxiety, clinical anxiety and female gender were hypothesized to act synergistically in red...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2015.0008

    authors： Dorfman J,Rosen D,Pine D,Ernst M

    更新日期：2016-05-01 00:00:00

  • Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations.

    abstract：OBJECTIVE:Irritability is both a normal developmental phenomenon and a common psychiatric symptom in children. In psychiatric nosology, a distinction is made between chronic and episodic irritability. This study examines the validity of this distinction. METHODS:A sample of 776 youths received Diagnostic and Statistic...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2006.16.456

    authors： Leibenluft E,Cohen P,Gorrindo T,Brook JS,Pine DS

    更新日期：2006-08-01 00:00:00

  • Striatal volume abnormalities in treatment-naïve patients diagnosed with pediatric major depressive disorder.

    abstract：OBJECTIVE:The striatum, including the putamen and caudate, plays an important role in executive and emotional processing and may be involved in the pathophysiology of mood disorders. Few studies have examined structural abnormalities of the striatum in pediatric major depressive disorder (MDD) patients. We report stria...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章

    doi：10.1089/cap.2007.0026

    authors： Matsuo K,Rosenberg DR,Easter PC,MacMaster FP,Chen HH,Nicoletti M,Caetano SC,Hatch JP,Soares JC

    更新日期：2008-04-01 00:00:00

  • Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine.

    abstract：OBJECTIVE:The aim of this study was to summarize results of a blinded review of potential suicidal events and analyses comparing incidence rates between paroxetine- and placebo-treated pediatric patients. METHOD:One thousand one hundred ninety-one (1191) children and adolescents received paroxetine (n = 642) or placeb...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,评审

    doi：10.1089/cap.2006.16.77

    authors： Apter A,Lipschitz A,Fong R,Carpenter DJ,Krulewicz S,Davies JT,Wilkinson C,Perera P,Metz A

    更新日期：2006-02-01 00:00:00

  • A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.

    abstract：OBJECTIVE:Recent studies have focused on the role of inflammatory cascades as one of the possible etiologic factors of bipolar disorder. We hypothesize that celecoxib, through its anti-inflammatory properties, may have a therapeutic role in acute bipolar mania. PATIENTS AND METHODS:Forty-two adolescent inpatients with...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1089/cap.2016.0207

    authors： Mousavi SY,Khezri R,Karkhaneh-Yousefi MA,Mohammadinejad P,Gholamian F,Mohammadi MR,Zeinoddini A,Akhondzadeh S

    更新日期：2017-08-01 00:00:00

  • Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.

    abstract：OBJECTIVES:This study examines cardiovascular (CV) effects of guanfacine immediate-release (GUAN-IR), dexmethylphenidate extended-release (DMPH), and their combination (COMB) during acute and long-term treatment of youth with attention-deficit/hyperactivity disorder. METHODS:Two hundred seven participants aged 7-14 ye...

    journal_title：Journal of child and adolescent psychopharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1089/cap.2015.0264

    authors： Sayer GR,McGough JJ,Levitt J,Cowen J,Sturm A,Castelo E,McCracken JT

    更新日期：2016-12-01 00:00:00